title: Continuous local intraarterial infusion after prolonged arterial stasis in the fingers and toes.
abstract: Seven patients with trauma to eight digits and one toe went untreated for arterial stasis, with subsequent development of posttraumatic changes in skin coloration. In two patients involving two digits, a daily dose of 2,000 ml containing 240,000 U urokinase, 80 micrograms prostaglandin E1, and 10,000 U heparin in lactated Ringer's solution was administered by intravenous infusion for 10 consecutive days; one of the two digits became necrotic. In all subsequent patients, a daily dose of 80 ml containing 240,000 U urokinase, 40 micrograms prostaglandin E1, 10,000 U (maximum) heparin, and low-molecular-weight dextran was administered by continuous local intraarterial infusion for 10 consecutive days. These seven extremities survived, even in the case of two digits and one toe with over 50 hr of arterial stasis. We believe that revascularization of extremities following prolonged periods of arterial stasis may be possible by means of continuous local intraarterial infusion of antithrombotic agents.
authors.affiliation: Department of Orthopedic Surgery, Omiwa Hospital, Nara, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Fukui
authors.forename: M
authors.initials: M
authors.lastname: Maeda
authors.forename: T
authors.initials: T
authors.lastname: Mine
authors.forename: Y
authors.initials: Y
authors.lastname: Inada
authors.forename: S
authors.initials: S
authors.lastname: Mizumoto
authors.forename: S
authors.initials: S
authors.lastname: Tamai
mesh_terms: D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage; D002648:Child; D003911:Dextrans / Q000008:administration & dosage; D005383:Finger Injuries / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007260:Infusion Pumps; D007261:Infusions, Intra-Arterial; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D011182:Postoperative Care; D012039:Regional Blood Flow / Q000187:drug effects; D014034:Toes / Q000293:injuries* / Q000503:physiopathology; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage; D014947:Wounds and Injuries / Q000503:physiopathology / Q000601:surgery / Q000628:therapy
chemical_list: D003911:Dextrans; D014568:Urokinase-Type Plasminogen Activator; D000527:Alprostadil